Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term
Elizabeth H Bradley1, Jeph Herrin, Brian Elbel
1Department of Epidemiology and Public Health, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Conn 06520-8088, USA.
JAMA
|July 6, 2006
Summary
Publicly reported acute myocardial infarction (AMI) process measures show moderate correlations but explain little variation in hospital mortality rates. Comprehensive quality assessment requires evaluating multiple processes and outcomes, including mortality rates.
Area of Science:
- Cardiology
- Health Services Research
- Quality Improvement
Background:
- Healthcare quality metrics are crucial for patient care evaluation.
- The Centers for Medicare & Medicaid Services (CMS) and Joint Commission on Accreditation of Healthcare Organizations (JCAHO) report acute myocardial infarction (AMI) process measures.
- Limited understanding exists regarding the correlation between these AMI process measures and their ability to predict hospital outcomes.
Purpose of the Study:
- To investigate the correlations among core process measures for acute myocardial infarction (AMI).
- To determine the extent to which these AMI process measures explain variations in hospital-specific, risk-standardized, 30-day mortality rates.
Main Methods:
- Analysis of 2002-2003 data from 962 hospitals in the National Registry of Myocardial Infarction (NRMI).
- Assessment of hospital performance on CMS/JCAHO AMI core process measures.
- Correlation of process measures with each other and with hospital-level, risk-standardized, 30-day mortality rates from Medicare claims data.
Main Results:
- Moderate to strong correlations were observed between medication adherence measures (beta-blockers, aspirin, ACE inhibitors).
- Weaker, yet statistically significant, correlations were found between medication measures and smoking cessation counseling or reperfusion times.
- The analyzed process measures collectively explained only 6.0% of the variation in hospital-level, risk-standardized, 30-day mortality rates for AMI patients.
Conclusions:
- Current publicly reported AMI process measures account for a small fraction of the variability in short-term hospital mortality.
- A comprehensive assessment of hospital performance necessitates the inclusion of multiple process measures and outcome indicators, such as risk-standardized mortality rates.
More Related Videos
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:26Acute Coronary Syndrome V: Nursing Management
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...